State Of Wyoming Alnylam Pharmaceuticals, Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$127.18 - $173.91 $11,954 - $16,347	-94 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$159.56 - $209.29 $7,499 - $9,836	-47 Reduced 33.33%	94 $16,000
Q3 2021 Feb 11, 2022	SELL	$169.75 - $207.73 $47,699 - $58,372	-281 Reduced 66.59%	141 $27,000
Q2 2021 Feb 11, 2022	BUY	$128.63 - $176.89 $21,609 - $29,717	168 Added 66.14%	422 $72,000
Q1 2021 Feb 08, 2022	BUY	$126.83 - $175.69 $32,214 - $44,625	254 New	254 $36,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.